Sample size for simultaneous testing of rate differences in non-inferiority trials with multiple endpoints

被引:11
|
作者
Song, James X. [1 ]
机构
[1] Hoffman La Roche Pharmaceut, Nutley, NJ 07110 USA
关键词
CLINICAL-TRIALS; NULL HYPOTHESIS; EQUIVALENCE; TABLES;
D O I
10.1016/j.csda.2008.10.028
中图分类号
TP39 [计算机的应用];
学科分类号
081203 ; 0835 ;
摘要
This paper discusses sample size estimation for several simultaneous tests of rate differences in non-inferiority trials. Formulae corresponding to the commonly used methods in a single endpoint study, which were proposed by [Blackwelder, W.C., 1982. Proving the null hypothesis in clinical trials. Controlled Clinical Trials 3, 345-353] and [Farrington, C.P., Manning, G., 1990. Test statistics and sample size formulae for comparative binomial trials with null hypothesis on non-zero risk difference or non-unity relative risk. Statistics in Medicine 9, 1447-1454] are presented. The focus of this study is a non-inferiority trial with multiple co-primary endpoints. The sample size for simultaneous testing is not only determined byType I and II error rates, but also by several other factors including the effect sizes of each endpoint, the number of endpoints and the correlation among test statistics in each endpoint. To demonstrate the sample sizes required to achieve various levels of statistical significance under different correlations, this manuscript presents plots of the distribution of P-values as a function of sample size. These plots are obtained simultaneously from each endpoint under the alternative hypothesis. The results are applied to the design of a non-inferiority trial. (C) 2008 Elsevier B.V. All rights reserved.
引用
收藏
页码:1201 / 1207
页数:7
相关论文
共 50 条
  • [1] Blinded sample size reestimation in non-inferiority trials with binary Endpoints
    Friede, Tim
    Mitchell, Charles
    Mueller-Velten, Guenther
    [J]. BIOMETRICAL JOURNAL, 2007, 49 (06) : 903 - 916
  • [2] Multiple assessments of non-inferiority trials with ordinal endpoints
    Xu, Wenfu
    Hou, Yuli
    Lu, Tong-Yu
    [J]. STATISTICS IN MEDICINE, 2023, 42 (08) : 1113 - 1126
  • [3] Sample size and the ethics of non-inferiority trials
    Powers, JH
    Cooper, CK
    Lin, D
    Ross, DB
    [J]. LANCET, 2005, 366 (9479): : 24 - 25
  • [4] Sample Size Reassessment in Non-inferiority Trials
    Friede, T.
    Kieser, M.
    [J]. METHODS OF INFORMATION IN MEDICINE, 2011, 50 (03) : 237 - 243
  • [5] Optimal sample size allocation for two-arm superiority and non-inferiority trials with binary endpoints
    Kirchner, Marietta
    Schuepke, Stefanie
    Kieser, Meinhard
    [J]. PHARMACEUTICAL STATISTICS, 2024,
  • [6] Comparison of three sample size calculation methods for non-inferiority vaccine trials with multiple continuous co-primary endpoints
    Yang, Jiaying
    Li, Jingxin
    Wang, Shiyuan
    Luo, Li
    Liu, Pei
    [J]. HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2019, 15 (01) : 256 - 263
  • [7] A combined superiority and non-inferiority approach to multiple endpoints in clinical trials
    Bloch, Daniel A.
    Lai, Tze Leung
    Su, Zheng
    Tubert-Bitter, Pascale
    [J]. STATISTICS IN MEDICINE, 2007, 26 (06) : 1193 - 1207
  • [8] Blinded sample size reassessment in non-inferiority and equivalence trials
    Friede, T
    Kieser, M
    [J]. STATISTICS IN MEDICINE, 2003, 22 (06) : 995 - 1007
  • [9] Design of vaccine equivalence/non-inferiority trials with correlated multiple binomial endpoints
    Kong, L.
    Kohberger, R. C.
    Koch, G. G.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2006, 16 (04) : 555 - 572
  • [10] Multiple comparisons in non-inferiority trials: Reaction to recent regulatory guidance on multiple endpoints in clinical trials
    Wiens, Brian L.
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2018, 28 (01) : 52 - 62